Harri V. Taranto

Mr. Taranto co-founded Symphony in 2002 and has many years of experience advising investors and management teams of pharmaceutical, biotechnology and related healthcare companies.
Prior to joining Symphony, he was a Managing Director and co-founder of Wilkerson Partners, a healthcare and life sciences strategy consulting firm.
Previously, Mr. Taranto was a co-founder and partner, for 17 years, with The Wilkerson Group and its successor, TWG/IBM Healthcare Consulting, where he was head of the Global Pharmaceutical practice.
Throughout his TWG/IBM career, he was instrumental in shaping strategy and investment opportunities for leading biopharmaceutical companies and private equity investors.
His clients have included industry leaders and emerging growth-stage companies, as well as private equity investment firms.
Prior to joining TWG, Mr. Taranto was a consultant with McKinsey & Company from 1980 to 1983.
Mr. Taranto is a director and Chairman of Symphony Evolution, Inc. and Symphony Dynamo, Inc., and a director of Symphony Allegro, Inc., all Symphony portfolio companies.
In addition, Mr. Taranto serves on the Business Council of Solera Capital LLC, the Board of Directors of MIQS, Inc. and the Advisory Board of Doctors of the World-USA. Mr. Taranto earned an MBA in Finance from Columbia University and received his BS in Electrical Engineering from Yale University.